These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 62007)

  • 1. Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate.
    Habib FK; Hammond GL; Lee IR; Dawson JB; Mason MK; Smith PH; Stitch SR
    J Endocrinol; 1976 Oct; 71(1):133-41. PubMed ID: 62007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
    Habib FK; Lee IR; Stitch SR; Smith PH
    J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign prostatic hypertrophic glands.
    Lahtonen R
    Prostate; 1985; 6(2):177-83. PubMed ID: 2579370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels.
    Habib FK; Goodman CM; Buck C
    Urol Res; 1992; 20(4):281-4. PubMed ID: 1380746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
    Ogunlewe JO; Osegbe DN
    Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endogenous androgen levels of human prostatic tissues].
    Morioka M; Takeda K; Mitsuhata N; Ohashi T; Ohmori H; Saito T; Kanbegawa A
    Nihon Naibunpi Gakkai Zasshi; 1982 Jul; 58(7):876-85. PubMed ID: 6182032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
    Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
    J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.
    Hammond GL
    J Endocrinol; 1978 Jul; 78(1):7-19. PubMed ID: 79632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the prostate: early diagnosis by zinc and hormone analysis?
    Habib FK; Mason MK; Smith PH; Stitch SR
    Br J Cancer; 1979 Jun; 39(6):700-4. PubMed ID: 87214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    Bard DR; Lasnitzki I
    J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate.
    Feustel A; Wennrich R
    Urol Res; 1984; 12(2):147-50. PubMed ID: 6204433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen concentration in blacks with benign and malignant prostatic disease.
    Osegbe DN; Ogunlewe JO
    J Urol; 1988 Jul; 140(1):160-4. PubMed ID: 2454327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
    Shiina H; Igawa M; Ishibe T
    Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgens and prostate-specific acid phosphatase in whole tissue and in separated epithelium from human benign prostatic hypertrophic glands.
    Bolton NJ; Lahtonen R; Vihko P; Kontturi M; Vihko R
    Prostate; 1981; 2(4):409-16. PubMed ID: 6173873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.
    Monti S; Di Silverio F; Iraci R; Martini C; Lanzara S; Falasca P; Poggi M; Stigliano A; Sciarra F; Toscano V
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1700-6. PubMed ID: 11297606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH).
    Feustel A; Wennrich R; Steiniger D; Klauss P
    Urol Res; 1982; 10(6):301-3. PubMed ID: 6186062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone, dihydrotestosterone, and zinc concentrations in human testis and epididymis.
    Suescun MO; Campo S; Rivarola MA; González-Echeverría F; Scorticati C; Ghirlanda J; Tezón J; Blaquier JA; Calandra RS
    Arch Androl; 1981 Dec; 7(4):297-303. PubMed ID: 7316603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.